Organon Reports Results for the First Quarter Ended March 31, 2024

First quarter 2024 revenue of $1,622 million, up 5% on an as-reported basis and 7% at constant currency



First quarter 2024 diluted earnings per share of $0.78 and non-GAAP Adjusted diluted...

Related Keywords

Japan ,United States ,Brazil ,Russia ,Canada ,China ,Jersey City ,New Jersey ,America ,Cozaar Hyzaar ,Eli Lilly ,Asia Pacific ,Kevin Ali ,Marvelon Mercilon ,Twitter ,Women Health ,Linkedin ,Merck Co Inc ,Organon Co ,Facebook ,Exchange Commission ,Instagram ,European Union ,Other Women Health ,Chief Executive ,Volume Based Procurement ,Established Brands ,Organon Investor Relations ,Securities Litigation Reform Act ,Annual Report ,Consolidated Statement ,Average Shares Outstanding ,Months Ended March ,Opioid Pain ,Non Opioid Pain ,Middle East ,Markets ,